 |
|
Leukocyte Count as a Predictor of Cardiovascular Events and Mortality in Postmenopausal Women
The Women’s Health Initiative Observational Study
Karen L. Margolis, MD, MPH;
JoAnn E. Manson, MD, DrPH;
Philip Greenland, MD;
Rebecca J. Rodabough, MS;
Paul F. Bray, MD;
Monika Safford, MD;
Richard H. Grimm, Jr, MD, PhD;
Barbara V. Howard, PhD;
Annlouise R. Assaf, PhD;
Ross Prentice, PhD; for the Women’s Health Initiative Research Group
Arch Intern Med. 2005;165:500-508.
Background Increasing evidence supports a role for inflammation in the atherosclerotic process. The role of the leukocyte count as an independent predictor of risk of a first cardiovascular disease (CVD) event remains uncertain. Our objective was to describe the relation between the baseline white blood cell (WBC) count and future CVD events and mortality in postmenopausal women.
Methods In this prospective cohort study set in 40 US clinical centers, the study population comprised 72 242 postmenopausal women aged 50 to 79 years, free of CVD and cancer at baseline, enrolled in the Women’s Health Initiative Observational Study. Main outcome measures included incident fatal coronary heart disease (CHD), nonfatal myocardial infarction, stroke, and total mortality.
Results At baseline, the mean ± SD age of the women was 63 ± 7.3 years, 84% were white, 4% had diabetes, 35% had hypertension, and 6% were current smokers. The mean WBC count was 5.8 ± 1.6x109 cells/L. During a mean of 6.1 years of follow-up, there were 187 CHD deaths, 701 nonfatal myocardial infarctions, 738 strokes, and 1919 deaths from all causes. Compared with women with WBC counts inthe first quartile (2.5-4.7x109 cells/L), women in the fourth quartile (6.7-15.0x109 cells/L) had over a 2-fold elevated risk for CHD death (hazard ratio, 2.36; 95% confidence interval, 1.51-3.68), after multivariable adjustment for age, race, diabetes, hypertension, smoking, hypercholesterolemia, body mass index, alcohol intake, diet, physical activity, aspirin use, and hormone use. Women in the upper quartile of the WBC count also had a 40% higher risk for nonfatal myocardial infarction, a 46% higher risk for stroke, and a 50% higher risk for total mortality. In multivariable models adjusting for C-reactive protein, the WBC count was an independent predictor of CHD risk, comparable in magnitude to C-reactive protein.
Conclusions The WBC count, a stable, well-standardized, widely available and inexpensive measure of systemic inflammation, is an independent predictor of CVD events and all-cause mortality in postmenopausal women. A WBC count greater than 6.7x109 cells/L may identify high-risk individuals who are not currently identified by traditional CVD risk factors.
A complete listing of the Women’s Health Initiative Research Group is given in a box at the end of this article.Author Affiliations: Hennepin County Medical Center, Minneapolis, Minn (Drs Margolis and Grimm); Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (Dr Manson); Northwestern University, Chicago, Ill (Dr Greenland); Fred Hutchinson Cancer Research Center, Seattle, Wash (Ms Rodabough and Dr Prentice); Baylor College of Medicine, Houston, Tex (Dr Bray); University of Alabama, Birmingham (Dr Safford); Medstar Research Institute/Howard University, Washington, DC (Dr Howard); Brown University, Pawtucket, RI (Dr Assaf).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Helfand et al.
ANN INTERN MED 2009;151:496-507.
ABSTRACT
| FULL TEXT
IL-17A Controls IL-17F Production and Maintains Blood Neutrophil Counts in Mice
von Vietinghoff and Ley
J. Immunol. 2009;183:865-873.
ABSTRACT
| FULL TEXT
Improving Mortality Prediction Using Biosocial Surveys
Goldman et al.
Am J Epidemiol 2009;169:769-779.
ABSTRACT
| FULL TEXT
Influence of Birth Weight on White Blood Cell Count in Biracial (Black-White) Children, Adolescents, and Young Adults: The Bogalusa Heart Study
Chen et al.
Am J Epidemiol 2009;169:214-218.
ABSTRACT
| FULL TEXT
Homeostatic Regulation of Blood Neutrophil Counts
von Vietinghoff and Ley
J. Immunol. 2008;181:5183-5188.
ABSTRACT
| FULL TEXT
Salivary Lysozyme and Prevalent Hypertension
Qvarnstrom et al.
JDR 2008;87:480-484.
ABSTRACT
| FULL TEXT
Age-related macular degeneration and mortality from cardiovascular disease or stroke
Tan et al.
Br J Ophthalmol 2008;92:509-512.
ABSTRACT
| FULL TEXT
Relationship Between a Systemic Inflammatory Marker, Plaque Inflammation, and Plaque Characteristics Determined by Intravascular Optical Coherence Tomography
Raffel et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:1820-1827.
ABSTRACT
| FULL TEXT
The Leukocyte Count, A Measure and Predictor of Coronary Events
Futterman and Lemberg
Am J Crit Care 2007;16:401-404.
FULL TEXT
Visual Impairment, Age-Related Macular Degeneration, Cataract, and Long-term Mortality: The Blue Mountains Eye Study
Cugati et al.
Arch Ophthalmol 2007;125:917-924.
ABSTRACT
| FULL TEXT
The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre?
Reaven
J. Am. Coll. Nutr. 2007;26:191-195.
FULL TEXT
Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease
Lavi et al.
Circulation 2007;115:2621-2627.
ABSTRACT
| FULL TEXT
White Blood Cell Count and Mortality in the Baltimore Longitudinal Study of Aging
Ruggiero et al.
J Am Coll Cardiol 2007;49:1841-1850.
ABSTRACT
| FULL TEXT
Association between Circulating White Blood Cell Count and Long-Term Incidence of Age-related Macular Degeneration: The Blue Mountains Eye Study
Shankar et al.
Am J Epidemiol 2007;165:375-382.
ABSTRACT
| FULL TEXT
Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group
Bushnell et al.
Stroke 2006;37:2387-2399.
ABSTRACT
| FULL TEXT
The metabolic syndrome: is this diagnosis necessary?
Reaven
Am. J. Clin. Nutr. 2006;83:1237-1247.
ABSTRACT
| FULL TEXT
Letter to the Editor: Salivary Lysozyme and Prevalent Coronary Heart Disease. Possible Effects of Oral Health on Endothelial Dysfunction
Janket et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:433-434.
FULL TEXT
Essential Thrombocythemia Beyond the First Decade: Life Expectancy, Long-term Complication Rates, and Prognostic Factors
Wolanskyj et al.
Mayo Clin Proc. 2006;81:159-166.
ABSTRACT
| FULL TEXT
Toward the Development of a Lab-on-a-Chip Dual-Function Leukocyte and C-Reactive Protein Analysis Method for the Assessment of Inflammation and Cardiac Risk
Christodoulides et al.
Clin. Chem. 2005;51:2391-2395.
FULL TEXT
Inflammation, Atherosclerosis, and Aspects of Insulin Action
Bloomgarden
Diabetes Care 2005;28:2312-2319.
FULL TEXT
Underlying Chronic Infection and Leukocyte Count
Janket and Meurman
Arch Intern Med 2005;165:1795-1795.
FULL TEXT
Leukocyte Response to Dental Plaque Accumulation: A Risk Factor for Heart Disease?
Kowolik and Dowsett
Arch Intern Med 2005;165:1795-1796.
FULL TEXT
Neutrophil Count and Complex Lesions in Patients With Coronary Artery Disease
Kaski et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:e112-e112.
FULL TEXT
WOMEN'S HEALTH INITIATIVE UPDATE: WBCs Predict CVD Risk
JWatch Women's Health 2005;2005:4-4.
FULL TEXT
WBC Count Predicts CV Events in Postmenopausal Women
Journal Watch Cardiology 2005;2005:7-7.
FULL TEXT
WBCs Predict CVD Events in Postmenopausal Women
JWatch General 2005;2005:3-3.
FULL TEXT
Leucocyte count may predict heart disease in women
Kermode-Scott
BMJ 2005;330:690.
FULL TEXT
Leukocyte Count in Vascular Risk Prediction
Cushman
Arch Intern Med 2005;165:487-488.
FULL TEXT
|
